Immunotherapy: Current Status and Future Perspectives

被引:0
|
作者
Charalampos S. Floudas
Gagandeep Brar
Tim F. Greten
机构
[1] National Institutes of Health,Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute
[2] National Institutes of Health,Liver Cancer Program, Center for Cancer Research, National Cancer Institute
来源
关键词
Hepatocellular carcinoma; Immunotherapy; CTLA-4 antigen; Programmed cell death 1 receptor; B7-H1 antigen; Adoptive cellular immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatocellular carcinoma (HCC) has an increasing incidence and dismal prognosis, with few systemic treatments approved, including several small molecule tyrosine kinase inhibitors. The application of immune checkpoint inhibitors (ICIs) to HCC has resulted in durable activity, and further evaluation is ongoing. In this review, we discuss the immunologic principles and the mechanism of action of the ICIs and present the relevant clinical data. Furthermore, we provide an overview of the current and emerging immunotherapeutic approaches for HCC, such as combination treatments, vaccines, and cellular therapies.
引用
收藏
页码:1030 / 1040
页数:10
相关论文
共 50 条
  • [21] Status of immunotherapy: Current and future
    Casale, TB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (06) : 1036 - 1039
  • [22] Immunotherapy for Melanoma: Current Status and Perspectives
    Alexandrescu, Doru T.
    Ichim, Thomas E.
    Riordan, Neil H.
    Marincola, Francesco M.
    Di Nardo, Anna
    Kabigting, Filamer D.
    Dasanu, Constantin A.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (06) : 570 - 590
  • [23] Current Status and Perspectives of the Immunotherapy of Leishmaniasis
    El-On, Joseph
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2009, 11 (10): : 623 - 628
  • [24] Applications and challenges of immunotherapy in the management of gastric adenocarcinoma: current status and future perspectives
    Zhiyao Chen
    Yunbin Ma
    Jianan Chen
    World Journal of Surgical Oncology, 23 (1)
  • [25] Current Status and Future Perspectives of Dendritic Cell-Based Cancer Immunotherapy
    Yi, D. H.
    Appel, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 78 (02) : 167 - 171
  • [26] The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
    Poyia, Fotini
    Neophytou, Christiana M.
    Christodoulou, Maria-Ioanna
    Papageorgis, Panagiotis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [27] The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives
    Walsh, Robert J.
    Tan, David S. P.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [28] Vaccines for cancer immunotherapy: An evidence-based review on current status and future perspectives
    Bharadwaj, Mausumi
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 150 (05) : 514 - 514
  • [29] Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
    Kim, Tae Jin
    Koo, Kyo Chul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 16
  • [30] Immunotherapy for sarcoma: Current state and future perspectives
    Pink, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 243 - 243